Investor
ASO GROUP Ltd
CIK 0002108771 · filed 2026-04-22 · SEC filing
13F book
$237.1K
Positions
56
2 new · 1 sold
Largest name
19.1%
Berkshire Hathaway Inc Del
Est. mark
−$13.1K
Price effect on 54 names still held. Flow −$5.73K.
| Name | Ticker | Shares | Value | Weight | Est. mark | Change |
|---|---|---|---|---|---|---|
| Berkshire Hathaway Inc Del | — | 63 | $45.2K | 19.1% | −$2.31K | Held |
| Alphabet Inc | — | 127.6K | $36.7K | 15.5% | −$3.25K | Held |
| Vanguard Index Fds | — | 61K | $36.4K | 15.4% | −$1.8K | Cut−$7.66K |
| Berkshire Hathaway Inc Del | — | 42.3K | $20.3K | 8.6% | −$966 | Added−$422 |
| Zoetis Inc. | ZTS | 71.9K | $8.5K | 3.6% | −$547 | Held |
| 3M CO | MMM | 53.1K | $7.72K | 3.3% | −$790 | Held |
| Brookfield Corp | — | 135.5K | $5.49K | 2.3% | −$735 | Held |
| Alphabet Inc | — | 17.6K | $5.05K | 2.1% | −$475 | Cut−$1.68K |
| Vontier Corp | VNT | 118.1K | $4.19K | 1.8% | −$202 | Held |
| Solventum Corp | SOLV | 62.6K | $4.09K | 1.7% | −$873 | Held |
| Lockheed Martin Corp | LMT | 6.63K | $4K | 1.7% | $800 | Held |
| Medtronic Plc | MDT | 41.9K | $3.63K | 1.5% | −$394 | Held |
| Johnson & Johnson | JNJ | 14.8K | $3.61K | 1.5% | $553 | Held |
| Ralliant Corp | RAL | 73.1K | $3.04K | 1.3% | −$681 | Held |
| Exxon Mobil Corp | — | 17.6K | $2.98K | 1.3% | $866 | Held |
| Kraft Heinz Co | KHC | 119.5K | $2.69K | 1.1% | −$210 | Held |
| Us Bancorp Del | — | 50.4K | $2.62K | 1.1% | −$68 | Held |
| Becton Dickinson & Co | BDX | 16.3K | $2.57K | 1.1% | −$520 | Added−$177 |
| Vanguard Specialized Funds | — | 11.9K | $2.56K | 1.1% | −$56 | Held |
| Fortive Corp | FTV | 42K | $2.32K | 1.0% | $3 | Held |
| Vanguard World Fd | — | 8.21K | $2.23K | 0.9% | −$127 | Held |
| Cigna Group | CI | 8.32K | $2.22K | 0.9% | −$70 | Held |
| Philip Morris Intl Inc | — | 11.3K | $1.87K | 0.8% | $56 | Held |
| Jacobs Solutions Inc. | J | 14.1K | $1.79K | 0.8% | −$73 | Held |
| Anheuser Busch Inbev Sa/Nv | — | 25.3K | $1.76K | 0.7% | $135 | Held |
| Gilead Sciences, Inc. | GILD | 10.9K | $1.51K | 0.6% | $181 | Held |
| Shell Plc | — | 15.9K | $1.48K | 0.6% | $310 | Held |
| Visa Inc. | V | 4.77K | $1.44K | 0.6% | −$231 | Held |
| Trimble Inc. | TRMB | 20.9K | $1.36K | 0.6% | −$274 | Held |
| Verisign Inc | — | 5.27K | $1.31K | 0.6% | $28 | Held |
| Nasdaq, Inc. | NDAQ | 14.8K | $1.26K | 0.5% | −$181 | Held |
| British Amern Tob Plc | — | 18.9K | $1.11K | 0.5% | $35 | Held |
| Microsoft Corp | MSFT | 2.78K | $1.03K | 0.4% | −$315 | Held |
| S&P Global Inc. | SPGI | 2.3K | $978 | 0.4% | −$223 | Held |
| Bristol-Myers Squibb Co | — | 15.1K | $917 | 0.4% | $102 | Held |
| Vanguard Intl Equity Index F | — | 14.4K | $776 | 0.3% | $4 | Held |
| Agilent Technologies, Inc. | A | 6.71K | $765 | 0.3% | −$148 | Held |
| Willis Towers Watson Plc | WTW | 2.47K | $718 | 0.3% | −$93 | Held |
| Occidental Pete Corp | — | 10.7K | $693 | 0.3% | $255 | Held |
| Brookfield Infrast Partners | — | 19.1K | $689 | 0.3% | — | New |
| Davita Inc. | DVA | 4.29K | $659 | 0.3% | $171 | Held |
| Veeva Sys Inc | — | 3.59K | $631 | 0.3% | −$171 | Held |
| Salesforce, Inc. | CRM | 3.33K | $621 | 0.3% | — | New |
| Henry Jack & Assoc Inc | — | 3.88K | $613 | 0.3% | −$94 | Held |
| Icon Plc | ICLR | 5.48K | $607 | 0.3% | −$392 | Held |
| Ametek Inc/ | AME | 2.81K | $603 | 0.3% | $26 | Held |
| Cvs Health Corp | CVS | 8K | $575 | 0.2% | −$60 | Held |
| Waters Corp | — | 1.91K | $570 | 0.2% | −$157 | Cut−$816 |
| Elevance Health Inc Formerly | — | 1.75K | $512 | 0.2% | −$101 | Held |
| Amentum Holdings, Inc. | AMTM | 17.7K | $462 | 0.2% | −$52 | Held |
| Dbx Etf Tr | — | 13.1K | $428 | 0.2% | −$3 | Held |
| Verizon Communications Inc | VZ | 8.14K | $409 | 0.2% | $77 | Held |
| Sensata Technologies Hldg Pl | — | 9.03K | $318 | 0.1% | $17 | Held |
| Las Vegas Sands Corp | LVS | 4.33K | $233 | 0.1% | −$49 | Held |
| Vanguard Scottsdale Fds | — | 2.07K | $207 | 0.1% | $1 | Held |
| Lumen Technologies, Inc. | LUMN | 10K | $70 | 0.0% | −$8 | Held |
Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.